These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17397244)

  • 1. Cardiovascular proteomics: past, present, and future.
    White MY; Van Eyk JE
    Mol Diagn Ther; 2007; 11(2):83-95. PubMed ID: 17397244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proteome profiling in canine idiopathic dilated cardiomyopathy using TMT-based quantitative proteomics approach.
    Bilić P; Guillemin N; Kovačević A; Beer Ljubić B; Jović I; Galan A; Eckersall PD; Burchmore R; Mrljak V
    J Proteomics; 2018 May; 179():110-121. PubMed ID: 29530679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
    J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].
    Banfi C; Brioschi M; Tremoli E
    G Ital Cardiol (Rome); 2013; 14(7-8):495-503. PubMed ID: 23877547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of proteomics in prognosis and treatment of cardiovascular diseases].
    Zuk N; Dubis J; Witkiewicz W
    Przegl Lek; 2013; 70(3):143-8. PubMed ID: 24003669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
    Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
    Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy.
    Liu S; Xia Y; Liu X; Wang Y; Chen Z; Xie J; Qian J; Shen H; Yang P
    Oncotarget; 2017 Jul; 8(29):48321-48332. PubMed ID: 28427148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Lindsey ML; Mayr M; Gomes AV; Delles C; Arrell DK; Murphy AM; Lange RA; Costello CE; Jin YF; Laskowitz DT; Sam F; Terzic A; Van Eyk J; Srinivas PR;
    Circulation; 2015 Sep; 132(9):852-72. PubMed ID: 26195497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular proteomic analysis.
    Suzuki T; Nagai R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):28-34. PubMed ID: 17350900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.
    Mokou M; Lygirou V; Vlahou A; Mischak H
    Expert Rev Proteomics; 2017 Feb; 14(2):117-136. PubMed ID: 27997814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics: state of the art and its application in cardiovascular research.
    Scobioala S; Klocke R; Michel G; Kuhlmann M; Nikol S
    Curr Med Chem; 2004 Dec; 11(24):3203-18. PubMed ID: 15579008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding different facets of cardiovascular diseases based on model systems to human studies: a proteomic and metabolomic perspective.
    Basak T; Varshney S; Akhtar S; Sengupta S
    J Proteomics; 2015 Sep; 127(Pt A):50-60. PubMed ID: 25956427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics in cardiovascular surgery.
    Matt P; Carrel T; White M; Lefkovits I; Van Eyk J
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):210-4. PubMed ID: 17198814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteomics and cardiovascular disease].
    Vivanco F; López-Bescós L; Tuñón J; Egido J
    Rev Esp Cardiol; 2003 Mar; 56(3):289-302. PubMed ID: 12622959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic approach in the search of new cardiovascular biomarkers.
    Gallego-Delgado J; Lazaro A; Osende JI; Barderas MG; Blanco-Colio LM; Duran MC; Martin-Ventura JL; Vivanco F; Egido J
    Kidney Int Suppl; 2005 Dec; (99):S103-7. PubMed ID: 16336560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiomics approach to identify novel biomarkers for dilated cardiomyopathy: Proteome and transcriptome analyses of 4C30 dilated cardiomyopathy mouse model.
    Nishigori M; Yagi H; Mochiduki A; Minamino N
    Biopolymers; 2016 Nov; 106(4):491-502. PubMed ID: 26799926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.